HIV Populations
FDA Approves Dolutegravir for Smaller Children with HIV
- Details
- Category: Children & Adolescents
- Published on Thursday, 16 June 2016 00:00
- Written by ViiV Healthcare
The U.S. Food and Drug Administration this week approved a supplemental indication for the HIV integrase inhibitor dolutegravir (Tivicay), allowing its use for children age 6 years and older who weigh as little as 30 kg. The drug is currently being evaluated in younger and smaller children.
High Prevalence of Geriatric Conditions Among HIV+ People Over Age 50 in San Francisco
- Details
- Category: HIV & Aging
- Published on Sunday, 08 May 2016 00:00
- Written by Michael Carter
Older HIV-positive people have a high prevalence of multiple age-related problems, investigators reported in the March 29 online edition of the Journal of Acquired Immune Deficiency Syndromes. The research involved people aged 50 years and older receiving outpatient care in San Francisco. Overall, 40% reported difficulties with daily activities, most reported loneliness, many had mild cognitive impairment, and 30% had only poor to fair quality of life.
California Demonstration Projects to Study HIV PrEP for Transgender People
- Details
- Category: Transgender People
- Published on Wednesday, 27 April 2016 00:00
- Written by UC San Diego Health
The California HIV/AIDS Research Program has announced funding for 3 new pre-exposure prophylaxis (PrEP) demonstration projects that will explore the use of Truvada (tenofovir/emtricitabine) for HIV prevention for transgender women and men, with a focus on improving adherence and monitoring interactions between antiretrovirals and gender-affirming hormone therapy.
Positively Trans Survey Looks at Lives of Transgender People Living with HIV
- Details
- Category: Transgender People
- Published on Wednesday, 27 April 2016 00:00
- Written by Liz Highleyman
The Transgender Law Center (TLC) released in March the first report of findings from its Positively Trans survey, which aims to learn more about the lives and experiences of transgender people living with HIV.TLC, working with a national advisory board of trans community leaders and with support from the Elton John AIDS Foundation, launched the survey in response to the structural inequities that drive the high rate of HIV/AIDS and poor health outcomes among trans people.
CROI 2016: Studies Probe Retention in Care for HIV+ Women Who Start ART During Pregnancy
- Details
- Category: Pregnancy & HIV MTCT
- Published on Tuesday, 12 April 2016 00:00
- Written by Carole Leach-Lemens
Engaging lay counselors to provide a combination package of evidence-based interventions in Nyanza, Kenya, and addressing partner disclosure, as well as pre-treatment education about the benefits of antiretroviral therapy (ART) for maternal and child health in Malawi’s Option B+ program improved retention in care and reduced loss to follow-up of mothers with HIV and their infants, studies presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2016) show.
More Articles...
- April 10 is National Youth HIV and AIDS Awareness Day
- CROI 2016: Cotrimoxazole Prophylaxis Provides No Benefit for HIV-Exposed Uninfected Children
- March 10 Is National Women and Girls HIV/AIDS Awareness Day
- CROI 2016: Transgender People at High Risk for HIV, But Little Is Known About Prevention and Treatment
Web Design and Development by